From smart route design to GMP supply
We develop and scale robust, efficient processes for small molecules—designed to perform consistently from early development through commercial readiness.
Process Development
We design scalable, impurity‑controlled routes with strong attention to yield, robustness, and long‑term manufacturability. Each process is built to transfer smoothly and support your project as it moves through clinical phases.
Analytical Development
Our analytical teams create phase‑appropriate methods (HPLC/UPLC, GC, LC–MS, chiral analysis) that deeply characterize your molecule and evolve with your program—from early screening to validation.
Drug Substance Analysis
We provide complete analytical packages, including identity, purity, assay, impurity profiling, residual solvents, and structural characterization—ensuring clarity and regulatory‑aligned documentation.
Stability Studies
ICH‑aligned long‑term and accelerated studies with clear trending and interpretation, supporting shelf life assignment, formulation decisions, and filings.
GMP Manufacturing
We manufacture drug substances under full GMP, offering flexible batch sizes, robust quality systems, and reliable delivery for clinical and commercial supply.